Literature DB >> 16477558

A tale of 2 alpha-herpesviruses: lessons for vaccinologists.

Barry T Rouse1, Shilpa Deshpande Kaistha.   

Abstract

Of the 8 known herpesviruses that affect human beings, we only have successful vaccines against varicella zoster virus. This brief review compares the pathogenesis of varicella zoster virus with that of the closely related alpha-herpesviruses herpes simplex virus 1 and 2, for which we have no satisfactory vaccines. The main objective of this review is to learn lessons from the success of varicella zoster virus vaccine that could be exploited for the development of successful vaccines against herpes simplex virus and perhaps against other herpes viruses.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16477558     DOI： 10.1086/500141

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  Therapeutic implications of new insights into the critical role of VP16 in initiating the earliest stages of HSV reactivation from latency.

Authors:  Richard L Thompson; Nancy M Sawtell
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

Review 2.  Some unmet challenges in the immunology of viral infections.

Authors:  Barry T Rouse; Aron E Lukacher
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

3.  The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia.

Authors:  Yo Hoshino; Jing Qin; Dean Follmann; Jeffrey I Cohen; Stephen E Straus
Journal:  Virology       Date:  2007-11-28       Impact factor: 3.616

4.  Herpes simplex and varicella zoster CNS infections: clinical presentations, treatments and outcomes.

Authors:  Quanhathai Kaewpoowat; Lucrecia Salazar; Elizabeth Aguilera; Susan H Wootton; Rodrigo Hasbun
Journal:  Infection       Date:  2015-12-17       Impact factor: 3.553

5.  Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3.

Authors:  Sarah Mackenzie-Dyck; Laura Latimer; Ethel Atanley; Jennifer Kovacs-Nolan; Sam Attah-Poku; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Clin Vaccine Immunol       Date:  2014-11-05

6.  Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.

Authors:  Wei Zhao; Stephen Spatz; Zhenyu Zhang; Guoyuan Wen; Maricarmen Garcia; Laszlo Zsak; Qingzhong Yu
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

7.  High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

Authors:  Zheming Lu; Richard Brans; Natali V Akhrameyeva; Nao Murakami; Ximing Xu; Feng Yao
Journal:  J Invest Dermatol       Date:  2008-11-13       Impact factor: 8.551

8.  Herpes simplex virus and varicella zoster virus, the house guests who never leave.

Authors:  Paul R Kinchington; Anthony J St Leger; Jean-Marc G Guedon; Robert L Hendricks
Journal:  Herpesviridae       Date:  2012-06-12

Review 9.  Immunity and immunopathology to viruses: what decides the outcome?

Authors:  Barry T Rouse; Sharvan Sehrawat
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

10.  Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.

Authors:  William P Halford; Joshua Geltz; Edward Gershburg
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.